Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema.

Jason G Powell Christopher R PiszczatoskiEric Rubido

Published in: The Annals of pharmacotherapy (2021)

Berotralstat 150 mg daily has been proven safe and effective in clinical studies and appears to be a viable oral alternative to parenteral medications currently used in HAE prophylaxis.

Keyphrases

physical activity